Interventional cardiology groups unite to push the specialty forward
Two leading healthcare groups, the Society for Cardiovascular Angiography and Interventions (SCAI) and Cardiovascular Research Technologies (CRT), have launched a new collaboration focused on advancing the field of interventional cardiology. They aim to achieve that goal through education, advocacy and future research initiatives.
One key aspect of this new collaboration will be the discounted registration SCAI members receive for CRT 2026, a four-day event in Washington, DC featuring keynote speaker President Joe Biden. In addition, SCAI is putting together a “Day on the Hill” event during CRT 2026 to help advocate for policies important to the interventional cardiology community.
SCAI and CRT also plan on working together to develop data registries and clinical trials. The two groups will secure external funding as needed to make these ventures a reality.
“Collaboration is key to the future of medicine—interventional cardiology in particular—and SCAI’s commitment to improve outcomes for our patients,” SCAI President Srihari S. Naidu, MD, an interventional cardiologist with New York Medical College, said in a statement. “SCAI and CRT share a common mission to advance interventional cardiology through collaboration, science, advocacy, regulatory policies and education. While coming at these goals from different vantage points, our new partnership reflects the growing alignment in vision, and SCAI looks forward to the many benefits of working together with CRT.”
“Through CRT’s collaboration with SCAI, we’re expanding the impact of both organizations,” added Ron Waksman, MD, associate director of cardiology with MedStar Health and the chair of CRT 2026. “This partnership allows us to connect clinical science, advocacy and education in ways that will drive innovation and bring together experts from across cardiovascular medicine. Our shared vision is to strengthen the pipeline of research, inspire the next generation of interventionalists, and ensure that patients everywhere benefit from the rapid progress being made in the interventional lab.”
Michael has more than 19 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.